J&J seeks US clearance for COVID-19 vaccine booster doses
@WSJ4 years ago
A trial testing whether a single dose of Johnson & Johnson’s vaccine can safely protect people from Covid-19 follows an earlier study that showed promising results. Four experimental coronavirus shots have now entered Phase 3 testing in the U.S. on.wsj.com
@WSJ4 years ago
Use of Johnson & Johnson's Covid-19 vaccine should resume, U.S. health regulators said. The shots could be back in circulation as soon as this weekend. on.wsj.com
@WSJ4 years ago
The recommended pause of Johnson & Johnson's vaccine, which makes up less than 5% of the recorded shots in arms in the U.S. to date, was “out of an abundance of caution,” says White House Covid-19 coordinator Jeff Zients on.wsj.com
@politico.com4 years ago
FDA authorizes Johnson & Johnson coronavirus vaccine
